1.
Clin Gastroenterol Hepatol
; 19(11): 2438-2440.e1, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34217880
RESUMO
Gastrointestinal (GI) symptoms are highly prevalent in coronavirus disease 2019 (COVID-19) ranging from 17.6 % to 53 %.1-4 The proposed mechanism for GI symptoms involves SARS-CoV-2 virus binding to the host cell's angiotensin-converting enzyme-2 receptor, commonly found in GI tract epithelial cells.5.